Compounds > ethyl 2-cyanoacrylate
Page last updated: 2024-09-24

ethyl 2-cyanoacrylate

Description

ethyl 2-cyanoacrylate: RN given refers to monomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID81530
CHEMBL ID1564920
SCHEMBL ID29445
MeSH IDM0092958

Synonyms (47)

Synonym
ec 230-391-5
unii-2g95foh7sf
hsdb 7910
2g95foh7sf ,
7085-85-0
NCGC00091046-01
ethyl cyanoacrylate
ccris 1693
einecs 230-391-5
acrylic acid, 2-cyano-, ethyl ester
ethyl 2-cyanoacrylate
2-propenoic acid, 2-cyano-, ethyl ester
ethyl 2-cyanoacrylate, liquid
ethyl 2-cyanoprop-2-enoate
NCGC00091046-02
dtxsid1025279 ,
dtxcid605279
NCGC00257131-01
cas-7085-85-0
tox21_303235
tox21_202453
NCGC00260002-01
25067-30-5
cyacrin
mk-2 glue
AKOS016009959
2-cyanoacrylic acid ethyl ester
FT-0626265
ethyl 2-cyanoacrylate [who-dd]
ethyl cyanoacrylate [mart.]
ethyl cyanoacrylate [mi]
ethyl cyanoacrylate [inci]
2-propenoic acid,2-cyano-, ethyl ester
SCHEMBL29445
CHEMBL1564920
ethyl-alpha-cyanoacrylate
.beta.-cyanoethyl acrylate
2-boc-aminomethyl-phenylboronicacid
cyanoacrylate adhesive
mfcd00045615
Q209366
AS-10071
D87637
EN300-112713
SY076979
A937456
CS-0141604

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency89.35840.007215.758889.3584AID1224835
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
RAR-related orphan receptor gammaMus musculus (house mouse)Potency34.37620.006038.004119,952.5996AID1159523
SMAD family member 2Homo sapiens (human)Potency19.49380.173734.304761.8120AID1346924
SMAD family member 3Homo sapiens (human)Potency19.49380.173734.304761.8120AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency17.91600.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency42.91470.000221.22318,912.5098AID1259243; AID1259247; AID743042
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency8.91250.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.95260.001318.074339.8107AID926; AID938
progesterone receptorHomo sapiens (human)Potency68.51990.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency75.51010.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency72.27380.001530.607315,848.9004AID1224841; AID1224842; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency61.13060.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency43.50870.000229.305416,493.5996AID743075; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency12.29980.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency38.89520.001019.414170.9645AID743191
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency30.63790.001723.839378.1014AID743083
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency61.64480.057821.109761.2679AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency126.79300.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency55.43130.000323.4451159.6830AID743065; AID743066; AID743067
heat shock protein beta-1Homo sapiens (human)Potency34.66540.042027.378961.6448AID743210
Cellular tumor antigen p53Homo sapiens (human)Potency61.13060.002319.595674.0614AID651631
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency62.32630.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency61.13060.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (141)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (40)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (26)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (177)

TimeframeStudies, This Drug (%)All Drugs %
pre-199046 (25.99)18.7374
1990's35 (19.77)18.2507
2000's63 (35.59)29.6817
2010's30 (16.95)24.3611
2020's3 (1.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (3.38%)5.53%
Reviews4 (1.93%)6.00%
Case Studies31 (14.98%)4.05%
Observational0 (0.00%)0.25%
Other165 (79.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Controlled Multicenter Trial to Evaluate the Effects of Ethyl-2-cyanoacrylate on Pain Intensity and Quality of Life in Head and Neck Cancer Patients Suffering From Cetuximab-induced Rhagades During Radioimmunotherapy[NCT01693159]50 participants (Anticipated)Interventional2011-05-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
hydroxyethyl methacrylate[no description available]medium40enoate esterallergen;
polymerisation monomer
octyl 2-cyanoacrylate[no description available]medium40
ethyl acrylate[no description available]medium10enoate ester
methylmethacrylate[no description available]medium30enoate ester;
methyl ester		allergen;
polymerisation monomer
gentian violet[no description available]medium20organic chloride saltanthelminthic drug;
antibacterial agent;
antifungal agent;
antiseptic drug;
histological dye
ninhydrin[no description available]medium20aromatic ketone;
beta-diketone;
indanones;
ketone hydrate		colour indicator;
human metabolite
ciprofloxacin[no description available]medium10aminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion		antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
acrylic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acidmetabolite
cellulose[no description available]medium10glycoside
titanium[no description available]medium20titanium group element atom
molybdenum disulfide[no description available]medium10sulfide salt
titanium dioxide[no description available]medium10titanium oxidesfood colouring
molybdenum[no description available]medium10chromium group element atommicronutrient
enbucrilate[no description available]medium150alpha,beta-unsaturated monocarboxylic acid;
nitrile
indium[no description available]medium10boron group element atom
indium trichloride[no description available]medium10
isopropyl myristate[no description available]medium10fatty acid ester
glycerol[no description available]medium10alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
zirconium[no description available]medium10titanium group element atom
methane[no description available]medium10alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
methyl 2-cyanoacrylate[no description available]medium40
silicate cement[no description available]medium20
cyanates[no description available]medium30
sorbitan monolaurate[no description available]medium10
ovalbumin[no description available]medium20
fluorescein-5-isothiocyanate[no description available]medium10fluorescein isothiocyanate
chloroform[no description available]medium10chloromethanes;
one-carbon compound		carcinogenic agent;
central nervous system drug;
inhalation anaesthetic;
non-polar solvent;
refrigerant
1-butanol[no description available]medium10alkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol		human metabolite;
mouse metabolite;
protic solvent
galactose[no description available]medium10
phenyl acetate[no description available]medium10benzenes;
phenyl acetates
butyl acetate[no description available]medium10acetate estermetabolite
ethyl acetate[no description available]medium10acetate ester;
ethyl ester;
volatile organic compound		EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
toluene[no description available]medium10methylbenzene;
toluenes;
volatile organic compound		cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
acetone[no description available]medium20ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
propylene glycol[no description available]medium10glycol;
propane-1,2-diols		allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
sodium lactate[no description available]medium10lactate salt;
organic sodium salt		food acidity regulator;
food preservative
alanine[no description available]medium10alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
isoamyl 2-cyanoacrylate[no description available]medium10
bucrylate[no description available]medium30
fibrinogen[no description available]medium30iditolfungal metabolite
1,3-indandione[no description available]medium10aromatic ketone;
beta-diketone;
indanones
sodium fluoride[no description available]medium20fluoride saltmutagen
n-butyl acrylate[no description available]medium10acrylate ester
2-isocyanatoethyl methacrylate[no description available]medium10
styrene[no description available]medium10styrenes;
vinylarene;
volatile organic compound		mouse metabolite;
mutagen;
plant metabolite
timolol[no description available]medium10timololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
pilocarpine[no description available]medium10pilocarpineantiglaucoma drug
methacholine chloride[no description available]medium10quaternary ammonium salt
menaquinone 6[no description available]medium151
vitamin mk 8[no description available]medium30menaquinoneEscherichia coli metabolite;
human metabolite
glycidyl nitrate[no description available]medium60
menaquinone 9[no description available]medium30menaquinoneEscherichia coli metabolite
diaminopimelic acid[no description available]medium502,6-diaminopimelic acid;
amino acid zwitterion		Escherichia coli metabolite
arsenic[no description available]medium10metalloid atom;
pnictogen		micronutrient
siderite[no description available]medium10carbonate mineral;
carbonate salt;
iron molecular entity;
one-carbon compound
menaquinone 7[no description available]medium70menaquinonebone density conservation agent;
cofactor;
Escherichia coli metabolite;
human blood serum metabolite;
Mycoplasma genitalium metabolite
carbonates[no description available]medium10carbon oxoanion
lysine[no description available]medium10aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
ubiquinone[no description available]medium20
chlorine[no description available]medium10diatomic chlorine;
gas molecular entity		bleaching agent
1,1,2-trichloroethane[no description available]medium10chloroethanes
ethylene dichloride[no description available]medium10chloroethaneshepatotoxic agent;
mutagen;
non-polar solvent
1,1,1-trichloroethane[no description available]medium10chloroethanespolar solvent
peptones[no description available]medium10
hydrochloric acid[no description available]medium20chlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride		mouse metabolite
tegafur[no description available]medium10organohalogen compound;
pyrimidines
poloxalene[no description available]medium20epoxide
cetyltrimethylammonium ion[no description available]medium10quaternary ammonium ion
fluorouracil[no description available]medium10nucleobase analogue;
organofluorine compound		antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
olaflur[no description available]medium10
bisphenol a-glycidyl methacrylate[no description available]medium10diarylmethane
fluorides[no description available]medium10halide anion;
monoatomic fluorine
haloperidol[no description available]medium10aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
kanamycin a[no description available]medium10kanamycinsbacterial metabolite
2,4-dinitrophenylhydrazine[no description available]medium10C-nitro compound;
phenylhydrazines		reagent
erythrosine[no description available]medium20
fluorescein[no description available]medium102-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorescent dye;
radioopaque medium
acetonitrile[no description available]medium10aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
phenytoin[no description available]medium10imidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
ethosuximide[no description available]medium10dicarboximide;
pyrrolidinone		anticonvulsant;
geroprotector;
T-type calcium channel blocker
carbamazepine[no description available]medium10dibenzoazepine;
ureas		analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
vitamin k semiquinone radical[no description available]medium30
vitamin k 1[no description available]medium41phylloquinones;
vitamin K		cofactor;
human metabolite;
plant metabolite
nifurtimox[no description available]medium10nitrofuran antibiotic
ampicillin[no description available]medium10beta-lactam antibiotic;
penicillin allergen;
penicillin		antibacterial drug
caffeine[no description available]medium10purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
acyclovir[no description available]medium102-aminopurines;
oxopurine		antimetabolite;
antiviral drug
metoclopramide[no description available]medium20benzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound		antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
betadex[no description available]medium10cyclodextrin
amoxicillin[no description available]medium10penicillin allergen;
penicillin		antibacterial drug
diethyl maleate[no description available]medium10ethyl ester;
maleate ester		glutathione depleting agent
idebenone[no description available]medium101,4-benzoquinones;
primary alcohol		antioxidant;
ferroptosis inhibitor
menatetrenone[no description available]medium21menaquinoneanti-inflammatory agent;
antioxidant;
bone density conservation agent;
human metabolite;
neuroprotective agent
vitamin k1 oxide[no description available]medium10
warfarin[no description available]medium10benzenes;
hydroxycoumarin;
methyl ketone
prospidium[no description available]medium10
quinoxalines[no description available]medium10mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
n-vinyl-2-pyrrolidinone[no description available]medium20pyrrolidin-2-ones
alpha-chymotrypsin[no description available]medium10
procaine[no description available]medium10benzoate ester;
substituted aniline;
tertiary amino compound		central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
ConditionIndicatedRelationship StrengthStudiesTrials
Ache0medium11
Active Hyperemia0low10
Acute Disease0low10
Acute Liver Injury, Drug-Induced0low10
Adenocarcinoma0low10
Adenocarcinoma, Basal Cell0low10
Adenocarcinoma, Granular Cell0low10
Adenocarcinoma, Oxyphilic0low10
Adenocarcinoma, Tubular0low10
Adenocystic Carcinoma0low10
Adenoma, Malignant0low10
Adhesions, Tissue0low10
Adverse Drug Event0medium11
Adverse Drug Reaction0medium11
Age-Related Osteoporosis0medium11
Allergic Contact Dermatitis0low140
Alloxan Diabetes0low10
Anal Fistula0low20
Aneurysm, Anterior Cerebral Artery0low30
Aneurysm, Anterior Communicating Artery0low30
Aneurysm, Basilar Artery0low30
Aneurysm, Cerebral0low30
Aneurysm, Intracranial0low30
Aneurysm, Middle Cerebral Artery0low30
Aneurysm, Posterior Cerebral Artery0low30
Aneurysm, Posterior Communicating Artery0low30
Aneurysm, Ruptured0low20
Anterior Cerebral Artery Aneurysm0low30
Anterior Communicating Artery Aneurysm0low30
Arterial Hyperemia0low10
Arteriovenous Malformations, Cerebral0low20
Asthma0low20
Asthma, Bronchial0low20
Atrophy of Gingiva0medium11
Attachment Loss, Periodontal0medium11
Autoimmune Diabetes0low20
AVM (Arteriovenous Malformation) Intracranial0low20
Bacterial Disease0low10
Bacterial Eye Infections0low10
Bacterial Infection0low10
Bacterial Infections0low10
Bacterial Ocular Infections0low10
Basilar Artery Aneurysm0low30
Berry Aneurysm0low30
Bleeding0low40
Blow Out Fracture0low10
Blow-Out Fractures0low10
Bone Diseases, Metabolic0low10
Bone Fractures0low30
Bone Loss, Age-Related0medium11
Bone Loss, Osteoclastic0low10
Bone Loss, Perimenopausal0medium11
Bone Loss, Postmenopausal0medium11
Bone Resorption0low10
Brain Aneurysm0low30
Brain Diseases0low10
Brain Disorders0low10
Brain Thrombosis0low10
Brain Thrombus0low10
Broken Bones0low30
Bronchial Asthma0low20
Bronchial Fistula0low20
Cancer of Esophagus0low10
Cancer of Head0medium11
Cancer of Head and Neck0medium11
Cancer of Neck0medium11
Cancer of Rectum0low30
Cancer of Stomach0low10
Cancer of the Esophagus0low10
Cancer of the Head0medium11
Cancer of the Head and Neck0medium11
Cancer of the Neck0medium11
Cancer of the Rectum0low30
Cancer of the Stomach0low10
Cancer of the Uterus0low10
Cancer of Uterus0low10
Carcinoma, Adenoid Cystic0low10
Carcinoma, Cribriform0low10
Carcinoma, Epidermoid0low10
Carcinoma, Granular Cell0low10
Carcinoma, Planocellular0low10
Carcinoma, Squamous0low10
Carcinoma, Squamous Cell0low10
Carcinoma, Tubular0low10
Carcinosarcoma0low10
Cardiac Rupture, Post-Infarction0low20
Cardiac Rupture, Traumatic0low20
Caries, Dental0low10
Carious Dentin0low10
Carious Lesions0low10
Central Nervous System Disorders, Intracranial0low10
Central Nervous System Intracranial Disorders0low10
Cerebral Aneurysm0low30
Cerebral Arteriovenous Malformations0low20
Cerebral Thrombosis0low10
Cerebral Thrombus0low10
Chemical and Drug Induced Liver Injury0low10
Chemically-Induced Liver Toxicity0low10
Cholecystoduodenal Fistula0low20
Chronic Disease0low20
Chronic Illness0low20
Chronic Lung Injury0low10
Chronically Ill0low20
CNS Disorders, Intracranial0low10
Colovesical Fistula0low20
Complication, Intraoperative0low20
Complication, Peroperative0low20
Complication, Postoperative0low50
Congenital Intracranial Arteriovenous Malformations0low20
Contact Dermatitis0low10
Conus Medullaris Syndrome0low10
Corneal Diseases0low10
Curling Ulcer0low10
Curling's Ulcer0low10
Cylindroma0low10
Cyst, Pulmonary Hydatid0low20
Cysts, Pulmonary Hydatid0low20
Decay, Dental0low10
Deficiency, Vitamin K0medium21
Dehiscence, Surgical Wound0low50
Dental Caries0low10
Dental Decay0low10
Dental White Spot0low10
Dental White Spots0low10
Dermatitis Venenata0low10
Dermatitis, Allergic Contact0low140
Dermatitis, Allergic Eczematous0low140
Dermatitis, Contact0low10
Dermatitis, Contact, Allergic0low140
Dermatitis, Occupational0low50
Dermatoses0medium11
Dermatosis0medium11
Dermatosis, Industrial0low50
Diabetes Mellitus, Brittle0low20
Diabetes Mellitus, Experimental0low10
Diabetes Mellitus, Insulin-Dependent0low20
Diabetes Mellitus, Insulin-Dependent, 10low20
Diabetes Mellitus, Juvenile-Onset0low20
Diabetes Mellitus, Ketosis-Prone0low20
Diabetes Mellitus, Sudden-Onset0low20
Diabetes Mellitus, Type 10low20
Diabetes Mellitus, Type I0low20
Diabetes, Autoimmune0low20
Digestive System Diseases0low10
Digestive System Disorders0low10
Disease Models, Animal0low10
Disease, Pulmonary0low20
Diseases, Occupational0low20
Diseases, Pulmonary0low20
Drug Side Effects0medium11
Drug Toxicity0medium11
Drug-Induced Acute Liver Injury0low10
Drug-Induced Liver Disease0low10
Drug-Induced Liver Injury0low10
Drug-Related Side Effects and Adverse Reactions0medium11
Duodenal Diseases0low10
Duodenal Ulcer0low10
Ear Diseases0low10
Echinococcoses, Pulmonary0low20
Echinococcosis, Pulmonary0low20
Eczema, Contact0low10
EHS Tumor0low10
Encephalon Diseases0low10
Encephalopathy0low10
Endometrial Diseases0low10
Enterocutaneous Fistula0low20
Esophageal Cancer0low10
Esophageal Fistula0low10
Esophageal Neoplasms0low10
Esophagus Cancer0low10
Esophagus Neoplasm0low10
Experimental Diabetes Mellitus0low10
Experimental Sarcoma0low10
Experimental Sarcomas0low10
Extramedullary Spinal Cord Compression0low10
Eye Infections, Bacterial0low10
Facial Dermatoses0low40
Facial Dermatosis0low40
Favre-Racouchot Syndrome0low40
Female Genital Diseases0low10
Fibroid0low10
Fibroid Tumor0low10
Fibroid Uterus0low10
Fibroids, Uterine0low10
Fibroma, Uterine0low10
Fibromyoma0low10
Finger Injuries0low10
Fistula0low20
Foreign-Body Reaction0low30
Fractures, Blow-Out0low10
Fractures, Bone0low30
Gastric Cancer0low10
Gastric Cancer, Familial Diffuse0low10
Gastric Neoplasms0low10
Gastric Ulcer0low20
Gastroduodenal Ulcer0low30
Gastrointestinal Hemorrhage0low30
Genital Diseases, Female0low10
Giant Intracranial Aneurysm0low30
Gingival Atrophy0medium11
Gingival Recession0medium11
Gynecologic Diseases0low10
Hand Dermatoses0low40
Hand Dermatosis0low40
Head and Neck Cancer0medium11
Head and Neck Neoplasm0medium11
Head and Neck Neoplasms0medium11
Head Cancer0medium11
Head Neoplasm0medium11
Head Neoplasms0medium11
Head, Neck Neoplasms0medium11
Heart Injuries0low20
Heart Rupture, Post-Infarction0low20
Heart Rupture, Traumatic0low20
Hematochezia0low30
Hemoperitoneum0low10
Hemoptysis0low10
Hemorrhage0low40
Hemorrhage, Gastrointestinal0low30
Hemothorax0low10
Hepatitis, Drug-Induced0low10
Hepatitis, Toxic0low10
Hepatobiliary Diseases0low10
Hepatobiliary Disorders0low10
Hernia, Inguinal0low10
Hydatid Cyst, Pulmonary0low20
Hydatid Cysts, Pulmonary0low20
Hydatidoses, Pulmonary0low20
Hydatidosis, Pulmonary0low20
Hyperemia0low10
Hypersensitivity, Contact0low10
IDDM0low20
Incontinentia Pigmenti Achromians0low10
Industrial Dermatosis0low50
Infection, Bacterial0low10
Infection, Postoperative Wound0low10
Infection, Surgical Wound0low10
Infections, Bacterial0low10
Infections, Bacterial Eye0low10
Infections, Bacterial Ocular0low10
Inguinal Hernia0low10
Inguinal Hernia, Direct0low10
Inguinal Hernia, Indirect0low10
Injuries, Finger0low10
Injuries, Heart0low20
Injuries, Surgical0low20
Insulin-Dependent Diabetes Mellitus 10low20
Intestinal Fistula0low20
Intestinal Obstruction0low10
Intracranial Aneurysm0low30
Intracranial Arteriovenous Malformation, Ruptured0low20
Intracranial Arteriovenous Malformations0low20
Intracranial Arteriovenous Malformations, Congenital0low20
Intracranial Central Nervous System Disorders0low10
Intracranial CNS Disorders0low10
Intracranial Thrombosis0low10
Intraoperative Complications0low20
Ischemia0low10
Itching0low10
Ito Syndrome0low10
Juvenile-Onset Diabetes0low20
Left Ventricular Dysfunction0low10
Leiomyoma0low10
Leiomyoma, Uterine0low10
Liver Injury, Drug-Induced0low10
Liver Injury, Drug-Induced, Acute0low10
Low Bone Density0low10
Low Bone Mineral Density0low10
Lung Diseases0low20
Lung Diseases, Obstructive0low10
Lung Injuries0low10
Lung Injury0low10
Marginal Ulcer0low30
Maxillary Sinusitis0low10
Metabolic Bone Diseases0low10
Middle Cerebral Artery Aneurysm0low30
Muscle Spasm0low10
Muscular Spasm0low10
Mycotic Aneurysm, Intracranial0low30
Myelopathy, Compressive0low10
Nail Diseases0low10
Nasal Catarrh0low10
Neck Cancer0medium11
Neck Neoplasm0medium11
Neck Neoplasms0medium11
Necrosis0low20
Neoplasms, Esophageal0low10
Neoplasms, Gastric0low10
Neoplasms, Head0medium11
Neoplasms, Head and Neck0medium11
Neoplasms, Neck0medium11
Neoplasms, Rectal0low30
Neoplasms, Stomach0low10
Neoplasms, Upper Aerodigestive Tract0medium11
Neoplasms, Uterine0low10
Neoplasms, Uterus0low10
Nerve Degeneration0low10
Neuroblastoma0low10
Neuron Degeneration0low10
Nodular Elastoidosis0low40
Nodular Elastosis0low40
Obstructive Lung Diseases0low10
Obstructive Pulmonary Diseases0low10
Occupational Dermatitis0low50
Occupational Diseases0low20
Occupational Illnesses0low20
Ocular Infections, Bacterial0low10
Orbital Fracture0low10
Orbital Fractures0low10
Osteoclastic Bone Loss0low10
Osteomyelitis0low10
Osteopenia0low10
Osteoporosis0medium11
Osteoporosis, Age-Related0medium11
Osteoporosis, Involutional0medium11
Osteoporosis, Post-Menopausal0medium11
Osteoporosis, Post-Traumatic0medium11
Osteoporosis, Postmenopausal0medium11
Osteoporosis, Senile0medium11
Otologic Diseases0low10
Otological Diseases0low10
Pain0medium11
Pain, Burning0medium11
Pain, Crushing0medium11
Pain, Migratory0medium11
Pain, Radiating0medium11
Pain, Splitting0medium11
Pancreatic Fistula0low10
Parodontosis0low10
Passive Hyperemia0low10
Peptic Ulcer0low30
Peptic Ulcer Perforation0low10
Perimenopausal Bone Loss0medium11
Periodontal Attachment Loss0medium11
Periodontal Diseases0low10
Periodontal Pocket0medium11
Periostitis0low10
Peripheral Nerve Injuries0low20
Peripheral Nerve Injury0low20
Peritonitis0low10
Peroperative Complications0low20
Pigmentation Disorders0low10
Pneumothorax0low10
Pneumothorax, Primary Spontaneous0low10
Pocket, Periodontal0medium11
Post-Infarction Heart Rupture0low20
Posterior Cerebral Artery Aneurysm0low30
Posterior Communicating Artery Aneurysm0low30
Postmenopausal Bone Loss0medium11
Postmenopausal Osteoporosis0medium11
Postoperative Complications0low50
Postoperative Wound Infection0low10
Pregnancy0medium31
Pressure Pneumothorax0low10
Primary Peritonitis0low10
Primary Spontaneous Pneumothorax0low10
Pruritis0low10
Pruritus0low10
Pulmonary Disease0low20
Pulmonary Diseases0low20
Pulmonary Echinococcoses0low20
Pulmonary Echinococcosis0low20
Pulmonary Hydatid Cyst0low20
Pulmonary Hydatid Cysts0low20
Pulmonary Hydatidoses0low20
Pulmonary Hydatidosis0low20
Pulmonary Injury0low10
Pyorrhea Alveolaris0low10
Reactive Hyperemia0low10
Recrudescence0low30
Rectal Cancer0low30
Rectal Fistula0low20
Rectal Neoplasms0low30
Rectal Tumors0low30
Rectovaginal Fistula0low10
Rectum Cancer0low30
Rectum Neoplasms0low30
Recurrence0low30
Relapse0low30
Retroperitoneal Neoplasms0low10
Rhinitis0low10
Ruptured Aneurysm0low20
Ruptured Intracranial Arteriovenous Malformation0low20
Sarcoma, Engelbreth-Holm-Swarm0low10
Sarcoma, Experimental0low10
Sarcoma, Jensen0low10
Sarcomas, Experimental0low10
Schamberg Disease0low10
Schamberg's Disease0low10
Sclerosis0low10
Secondary Peritonitis0low10
Senile Osteoporosis0medium11
Sensitivity and Specificity0low20
Sensitivity, Contact0low10
Side Effects of Drugs0medium11
Sinusitis, Maxillary0low10
Skin and Subcutaneous Tissue Disorders0medium11
Skin Diseases0medium11
Spasm0low10
Spasm, Ciliary Body0low10
Spasm, Generalized0low10
Spinal Cord Compression0low10
Spinal Cord Compression, Extramedullary0low10
Spiral Fractures0low30
Spontaneous Pneumothorax0low10
Squamous Cell Carcinoma0low10
Stasis Ulcer0low10
Stomach Cancer0low10
Stomach Neoplasms0low10
Stomach Ulcer0low20
Streptozocin Diabetes0low10
Streptozotocin Diabetes0low10
Suffering, Physical0medium11
Surgery-Induced Tissue Adhesions0low10
Surgical Adhesions0low10
Surgical Injuries0low20
Surgical Site Infection0low10
Surgical Wound Dehiscence0low50
Surgical Wound Infection0low10
Tension Pneumothorax0low10
Thrombosis, Brain0low10
Thrombosis, Intracranial0low10
Thrombus, Intracranial0low10
Tissue Adhesions0low10
Tooth Diseases0low10
Torsion Fractures0low30
Toxic Hepatitis0low10
Toxicity, Drug0medium11
Tracheal Diseases0low10
Type 1 Diabetes0low20
Type 1 Diabetes Mellitus0low20
UADT Neoplasm0medium11
UADT Neoplasms0medium11
Upper Aerodigestive Tract Neoplasm0medium11
Upper Aerodigestive Tract Neoplasms0medium11
Uterine Cancer0low10
Uterine Diseases0low10
Uterine Neoplasms0low10
Uterus Cancer0low10
Uterus Neoplasms0low10
Vaginal Fistula0low10
Varicose Ulcer0low10
Venous Congestion0low10
Venous Engorgement0low10
Venous Hypertension Ulcers0low10
Venous Stasis Ulcers0low10
Venous Ulcer0low10
Ventricular Dysfunction, Left0low10
Vesico-Ureteral Reflux0low10
Vesicoureteral Reflux0low10
Vesicoureteral Reflux 10low10
Vitamin K Deficiency0medium21
White Spot, Dental0low10
White Spots, Dental0low10
Wound Dehiscence, Surgical0low50
Wound Infection, Postoperative0low10
Wound Infection, Surgical0low10

Research Highlights

Safety/Toxicity (7)

ArticleYear
N-butyl cyanoacrylate- and alpha-cyanoacrylate induced hepatotoxicity and venous sclerosis in a rabbit model.
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, Volume: 17, Issue: 1		2016
Cytotoxicity testing of methyl and ethyl 2-cyanoacrylate using direct contact assay on osteoblast cell cultures.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, Volume: 71, Issue: 1		2013
Cyanoacrylate in nerve repair: transient cytotoxic effect.
International journal of oral and maxillofacial surgery, Volume: 39, Issue: 7		2010
In vitro toxicity test of ethyl 2-cyanoacrylate, a tissue adhesive used in cardiovascular surgery, by fibroblast cell culture method.
The heart surgery forum, Volume: 8, Issue: 3		2005
Toxicity of cyanoacrylates in vitro using extract dilution assay on cell cultures.
Biomaterials, Volume: 15, Issue: 2		1994
Histotoxicity of cyanoacrylate tissue adhesives. A comparative study.
Archives of otolaryngology--head & neck surgery, Volume: 116, Issue: 5		1990
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (1)

ArticleYear
Different application volumes of ethyl-cyanoacrylate tissue adhesive can change its antibacterial effects against ocular pathogens in vitro.
Current eye research, Volume: 33, Issue: 10		2008
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (2)

ArticleYear
Polymeric nanoparticles as an oral delivery system for biocontrol agents for the brushtail possum (Trichosurus vulpecula).
New Zealand veterinary journal, Volume: 57, Issue: 6		2009
Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.
Journal of pharmaceutical sciences, Volume: 90, Issue: 3		2001
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (3)

ArticleYear
Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.
Biomaterials, Volume: 22, Issue: 21		2001
Variations in warfarin concentration in blood and coagulant factors after artificial valve replacement.
Artery, Volume: 19, Issue: 6		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (1)

ArticleYear
Haemostatic efficacy of an ethyl-2-cyanoacrylate-based aerosol in combination with tourniquet application in a large wound model with an arterial injury.
Injury, Volume: 39, Issue: 1		2008
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]